Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    OK!

    A Genetic Model for Central Chondrosarcoma Evolution Correlates with Patient Outcome

    November 23rd, 2021View ORCID ProfileWilliam Cross, Iben Lyskjær, Tom Lesluyes, Steven Hargreaves, Anna-Christina Strobl, Christopher Davies, Sara Waise, Shadi Hames, Dahmane Oukrif, Hongtao Ye, Fernanda Amary, Roberto Tirabosco, Toby Baker, David Barnes,...

    Read Article

    Chondrosarcoma Foundation Initiates a Fund-Raising Drive to Create a Patient Registry to Promote Research and Improve Care

    November 22nd, 2021In our on-going effort to promote more research, clinical trials, improve treatment and seek a cure for Chondrosarcoma, the CS Foundation is in the process of establishing a contractual partnership with NORD: National Organization for Rare Disorders...

    Read Article

    Cold Atmospheric Plasma Treatment of Chondrosarcoma Cells Affects Proliferation and Cell Membrane Permeability

    November 21st, 2021 by Lyubomir Haralambiev 1,2,*, Andreas Nitsch 1, Josephine M. Jacoby 1, Silas Strakeljahn 1, Sander Bekeschus 3, Alexander Mustea 4, Axel Ekkernkamp 1,2 and Matthias B. Stope 4 1 Department of Trauma, Reconstructive Surgery and Rehabilitation...

    Read Article

    Roses’s Journey with Chondrosarcoma

    November 12th, 2021Rose Truong Paderanga Hi all- I was recently featured on the local news for the surgery for my chondrosarcoma and wanted to share… Medical advancements are happening all the time guys. Don’t give up hope. We’re in this together. ...

    Read Article

    TBX3 in Combination with c-Myc and Nucleolin as Multiple Markers for the Early Detection of Sarcomas

    November 2nd, 2021Project ended 30 June 2020 Prof Sharon Prince Department of Human Biology/Division of Cell Biology, University of Cape Town Email Title of the project TBX3 in combination with c-Myc and Nucleolin as multiple markers for the early detection of...

    Read Article

    Research on Sarcomas from CANSA – The Cancer Association of South Africa

    November 1st, 2021TBX3 in Combination with c-Myc and Nucleolin as Multiple Markers for the Early Detection of Sarcomas Project ended 30 June 2020 Prof Sharon Prince Prof Sharon Prince Department of Human Biology/Division of Cell Biology, University of Cape...

    Read Article

    Research finds biomarker that could offer pathologists an accurate test to diagnose and stage chondrosarcoma

    October 14th, 2021A research project funded by the Bone Cancer Research Trust has found a promising clinical biomarker that offers pathologists an accurate and reproducible test to diagnose and stage chondrosarcoma, informing clinical management and deciding the type...

    Read Article

    National Organization for Rare Disorders is a huge resource for patients with Rare Cancers

    October 12th, 2021NORD Offers Information and Support for Patients of Rare Cancers November 24, 2014 Peter L. Saltonstall CURE, Winter 2014, Volume 13, Issue 4 NORD was founded in 1983 by parents of children with rare diseases. Over the past 30 years, it has become...

    Read Article